Modulation of endothelial lipase expression
Patent Information
- Authority / Receiving Office
- US · United States
- Current Assignee / Owner
- IONIS PHARMA INC
- Publication Date
- 2007-01-25
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
RELATED APPLICATIONS
[0001] This application is a continuation-in-part of U.S. patent application Ser. No. 10 / 319,915, filed Dec. 12, 2002. This application is also a continuation-in-part of U.S. patent application Ser. No. 11 / 036,095, filed Jan. 14, 2005; which is a continuation-in-part of the following U.S. patent applications: Ser. No. 10 / 187,110, filed Jun. 29, 2002; Ser. No. 10 / 303,328, filed Nov. 22, 2002; Ser. No. 10 / 302,028, filed Nov. 21, 2002; Ser. No. 10 / 293,866, filed Nov. 11, 2002; Ser. No. 10 / 316,241, filed Dec. 9, 2002; Ser. No. 10 / 317,401, filed Dec. 11, 2002; Ser. No. 10 / 210,556, filed Jul. 31, 2002; Ser. No. 10 / 210,723, filed Jul. 31, 2002; Ser. No. 10 / 318,389, filed Dec. 11, 2002; Ser. No. 10 / 302,027, filed Nov. 21, 2002; Ser. No. 10 / 300,399, filed Nov. 19, 2002; Ser. No. 10 / 189,429, filed Jul. 3, 2002; Ser. No. 10 / 174,020, filed Jun. 17, 2002; Ser. No. 10 / 177,554, filed Jun. 20, 2002; Ser. No. 10 / 185,035, filed Jun. 28, 2002; Ser. No. 10 / 316,755, filed Dec. 10, 2...